<prompt> Answer this question truthfullyWhich selective estrogen receptor modulator SERM is the preferred treatment option for postmenopausal osteoporosis, particularly for those at risk of breast cancer?  <response>: <reason> Raloxifene is the preferred selective estrogen receptor modulator SERM for the treatment of postmenopausal osteoporosis, especially for those at risk of breast cancer. 